• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过映射和计数乳腺切除标本中导管原位癌的块数对大小估计进行比较分析。

Comparative analysis of size estimation by mapping and counting number of blocks with ductal carcinoma in situ in breast excision specimens.

作者信息

Dadmanesh Farnaz, Fan Xuemo, Dastane Aditi, Amin Mahul B, Bose Shikha

机构信息

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

出版信息

Arch Pathol Lab Med. 2009 Jan;133(1):26-30. doi: 10.5858/133.1.26.

DOI:10.5858/133.1.26
PMID:19123732
Abstract

CONTEXT

The size of ductal carcinoma in situ (DCIS) is a significant predictor of local tumor recurrence and is used for selection of patients for conservative versus aggressive therapy. A standardized method for size assessment is lacking.

OBJECTIVE

To evaluate 2 commonly used methods for measurement of DCIS extent: one based on the distribution of the lesion in sequential series of sections (mapping method) and the other on the number of sections with DCIS (block method).

DESIGN

Ninety-eight consecutive cases of DCIS, measuring at least 1.0 cm, were retrieved from our files. All specimens were serially sectioned along the long axis. The size of DCIS was calculated for each case by 2 different methods: (1) mapping method (average thickness of each slice x number of consecutive slices with DCIS) and (2) block method (number of blocks with DCIS x 0.3 cm). Additional calculations were performed by using 0.35, 0.4, and 0.5 cm as multiplication factors for the block method in order to improve concordance.

RESULTS

The block method underestimated the size in 71 cases (72%) by 4.5% to 81.3% (mean, 33%). Using 0.4 cm as the multiplication factor improved concordance, while multiplying by 0.5 cm led to an overestimation of size.

CONCLUSIONS

Assessment of DCIS size by the block method is inaccurate and underestimates size in most cases (72%), with an average reduction of 33%. Using 0.4 cm as the multiplication factor improves concordance. A standardized method for size estimation is necessary for effective patient management.

摘要

背景

导管原位癌(DCIS)的大小是局部肿瘤复发的重要预测指标,用于选择接受保守治疗还是积极治疗的患者。目前缺乏一种标准化的大小评估方法。

目的

评估两种常用的测量DCIS范围的方法:一种基于病变在连续切片系列中的分布(映射法),另一种基于含有DCIS的切片数量(切块法)。

设计

从我们的档案中检索出98例连续的DCIS病例,其大小至少为1.0 cm。所有标本均沿长轴进行连续切片。通过两种不同方法计算每个病例的DCIS大小:(1)映射法(每片的平均厚度×含有DCIS的连续切片数量)和(2)切块法(含有DCIS的块数×0.3 cm)。为了提高一致性,在切块法中还分别使用0.35 cm、0.4 cm和0.5 cm作为相乘因子进行了额外计算。

结果

切块法在71例(72%)病例中低估了大小,低估幅度为4.5%至81.3%(平均为33%)。使用0.4 cm作为相乘因子可提高一致性,而乘以0.5 cm则导致大小被高估。

结论

用切块法评估DCIS大小不准确,在大多数病例(72%)中低估了大小,平均减少33%。使用0.4 cm作为相乘因子可提高一致性。有效的患者管理需要一种标准化的大小估计方法。

相似文献

1
Comparative analysis of size estimation by mapping and counting number of blocks with ductal carcinoma in situ in breast excision specimens.通过映射和计数乳腺切除标本中导管原位癌的块数对大小估计进行比较分析。
Arch Pathol Lab Med. 2009 Jan;133(1):26-30. doi: 10.5858/133.1.26.
2
Measuring extent of ductal carcinoma in situ in breast excision specimens: a comparison of 4 methods.测量乳腺切除标本中原位导管癌的范围:四种方法的比较
Arch Pathol Lab Med. 2009 Jan;133(1):31-7. doi: 10.5858/133.1.31.
3
Location and extent of positive resection margins and ductal carcinoma in situ in lumpectomy specimens of ductal breast carcinoma examined with a microscopic three-dimensional view.采用显微三维视图检查的乳腺导管癌肿块切除标本中,阳性切缘及导管原位癌的位置和范围。
Breast J. 2003 Jan-Feb;9(1):33-8. doi: 10.1046/j.1524-4741.2003.09108.x.
4
Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.通过连续宏观切片检查的367例乳腺导管原位癌回顾性系列研究中Van Nuys预后指数的应用:实际考量
Breast Cancer Res Treat. 2000 May;61(2):151-9. doi: 10.1023/a:1006437902770.
5
Reporting the greatest linear extent of ductal carcinoma in situ on needle core biopsy.报告针芯活检中导管原位癌的最大线性范围。
Hum Pathol. 2016 Apr;50:140-5. doi: 10.1016/j.humpath.2015.12.007. Epub 2015 Dec 30.
6
The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.乳腺肿块切除边缘评估作为乳腺导管原位癌残余肿瘤负荷预测指标的价值。
Cancer. 2002 Apr 1;94(7):1917-24. doi: 10.1002/cncr.10460.
7
Coronal serial sequential sampling of breast specimen in the assessment of the extent of ductal carcinoma in situ.在评估导管原位癌范围时对乳腺标本进行冠状面连续顺序取样。
Arch Pathol Lab Med. 2009 Sep;133(9):1362; author reply 1362-3. doi: 10.5858/133.9.1362.b.
8
Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.靶向术中放疗用于治疗乳腺导管原位癌
Breast J. 2016 Jan-Feb;22(1):63-74. doi: 10.1111/tbj.12516. Epub 2015 Nov 3.
9
Mammographic extent of microcalcifications and oestrogen receptor expression affect preoperative breast carcinoma in situ size estimation.乳腺钼靶检查中微钙化的范围和雌激素受体表达影响术前原位乳腺癌大小的估计。
Breast Cancer. 2017 May;24(3):466-472. doi: 10.1007/s12282-016-0729-9. Epub 2016 Sep 17.
10
Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age.基于患者年龄的乳腺导管原位癌病理特征差异。
Cancer. 2000 Jun 1;88(11):2553-60. doi: 10.1002/1097-0142(20000601)88:11<2553::aid-cncr18>3.0.co;2-v.

引用本文的文献

1
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression.一种用于识别进展风险较低的导管原位癌的形态计量学特征。
NPJ Precis Oncol. 2025 Jan 28;9(1):25. doi: 10.1038/s41698-024-00769-6.
2
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer.基于人工智能的形态计量学特征用于识别原位导管癌,其进展为浸润性乳腺癌的风险较低。
Res Sq. 2023 Dec 13:rs.3.rs-3639521. doi: 10.21203/rs.3.rs-3639521/v1.
3
Routine Use of a Standardized Mastectomy Diagram by Surgeons Improves Accuracy and Timeliness of the Final Pathological Report.
外科医生常规使用标准化乳房切除术示意图可提高最终病理报告的准确性和及时性。
Ann Surg Oncol. 2023 Nov;30(12):7124-7130. doi: 10.1245/s10434-023-14179-8. Epub 2023 Aug 19.
4
Ultrasonographic features of ductal carcinoma in situ: analysis of 219 lesions.导管原位癌的超声特征:219个病灶分析
Gland Surg. 2020 Dec;9(6):1945-1954. doi: 10.21037/gs-20-428.
5
Characteristics of ultrasonographic images of ductal carcinoma in situ with abnormalities of the ducts.伴有导管异常的原位导管癌超声图像特征
J Med Ultrason (2001). 2020 Jan;47(1):107-115. doi: 10.1007/s10396-019-00981-z. Epub 2019 Oct 26.
6
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary.残胰发生的胰腺癌并不总是先前原发性肿瘤的复发。
Mod Pathol. 2019 May;32(5):659-665. doi: 10.1038/s41379-018-0183-7. Epub 2018 Nov 22.
7
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma.伴有破骨细胞样巨细胞的胰腺未分化癌在基因上与传统导管腺癌相似,但在临床上有所不同。
J Pathol. 2017 Oct;243(2):148-154. doi: 10.1002/path.4941. Epub 2017 Sep 5.
8
Imaging-assisted large-format breast pathology: program rationale and development in a nonprofit health system in the United States.影像辅助的大尺寸乳腺病理学:美国一家非营利性医疗系统的项目原理与发展
Int J Breast Cancer. 2012;2012:171792. doi: 10.1155/2012/171792. Epub 2012 Dec 17.
9
The role of large-format histopathology in assessing subgross morphological prognostic parameters: a single institution report of 1000 consecutive breast cancer cases.大体病理检查在评估大体形态学预后参数中的作用:一家机构对1000例连续乳腺癌病例的报告
Int J Breast Cancer. 2012;2012:395415. doi: 10.1155/2012/395415. Epub 2012 Oct 21.
10
Automated reconstruction algorithm for identification of 3D architectures of cribriform ductal carcinoma in situ.自动重建算法用于识别原位筛状导管癌的三维结构。
PLoS One. 2012;7(9):e44011. doi: 10.1371/journal.pone.0044011. Epub 2012 Sep 6.